This focuses on review one of the methods of locoregional treatment \u96 intraarterial hepatic infusion. Metastatic hepatic malignancies are the leading cause of cancer death. Surgical resection of metastatic hepatic malignancies has been the only established treatment modality offering potential for cure. Although surgical resection has significantly improved survival, only 5\u9620 percent of patients with colorectal carcinoma metastatic to the liver are surgical candidates. Conventional systemic (intravenous) chemotherapy with fluoropirimidines is effective only for 10\u9621 percent of patients with metastatic colorectal carcinoma. The limitations of surgical resection and the limited efficacy and generalized toxicity of systemic chemothe...
Liver is the main target for colorectal cancer (CRC) metastases. About 50% of all patients affected ...
Liver metastases (LM) are often consequences of colo-rectal cancer (CRC)and the majority of patients...
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limita...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
AIM: Regional chemotherapy using hepatic artery catheters is a good method of treating patients with...
The aim was to investigate whether intra-arterial infusion of chemotherapy improves response to trea...
Background: Since the early 1990s, the minimally invasive image-guided therapies used in interventio...
Intraarterial procedures such as chemoembolization and radioembolization aim for the palliative trea...
Stefano Bacchetti, Enricomaria Pasqual, Elena Crozzolo, Alessandra Pellarin, Pier Paolo CagolDepartm...
Background: Only 5-10% of colorectal cancer patients (pts) with liver metastases are eligible for su...
Median survival of untreated patients with LM from CC ranges from 3 to 12 months (m) after diagnosis...
IS THERE A ROLE FOR INTRA-ARTERIAL THERAPY OR ISOLATED LIVER PERFUSION? Pr Olivier Detry, Dpt of ...
BACKGROUND: The practice of adjuvant hepatic arterial infusion chemotherapy (HAIC) for colorectal li...
About 50% of patients with colorectal cancer (CCR) are destined to develop hepatic metastases during...
Liver is the main target for colorectal cancer (CRC) metastases. About 50% of all patients affected ...
Liver metastases (LM) are often consequences of colo-rectal cancer (CRC)and the majority of patients...
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limita...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
The liver is the most common site of metastatic spread of colorectal cancer (CRC). Liver may be the ...
AIM: Regional chemotherapy using hepatic artery catheters is a good method of treating patients with...
The aim was to investigate whether intra-arterial infusion of chemotherapy improves response to trea...
Background: Since the early 1990s, the minimally invasive image-guided therapies used in interventio...
Intraarterial procedures such as chemoembolization and radioembolization aim for the palliative trea...
Stefano Bacchetti, Enricomaria Pasqual, Elena Crozzolo, Alessandra Pellarin, Pier Paolo CagolDepartm...
Background: Only 5-10% of colorectal cancer patients (pts) with liver metastases are eligible for su...
Median survival of untreated patients with LM from CC ranges from 3 to 12 months (m) after diagnosis...
IS THERE A ROLE FOR INTRA-ARTERIAL THERAPY OR ISOLATED LIVER PERFUSION? Pr Olivier Detry, Dpt of ...
BACKGROUND: The practice of adjuvant hepatic arterial infusion chemotherapy (HAIC) for colorectal li...
About 50% of patients with colorectal cancer (CCR) are destined to develop hepatic metastases during...
Liver is the main target for colorectal cancer (CRC) metastases. About 50% of all patients affected ...
Liver metastases (LM) are often consequences of colo-rectal cancer (CRC)and the majority of patients...
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limita...